CI
45
2
HP
36
2
ORLY
58
8
ACN
22
6
CNP
70
2
PFE
45
-15
KMX
42
2
KO
47
3
AIV
34
4
BSX
42
2
INTC
61
5
AES
46
2
PG
20
-2
WM
80
6
TXT
70
-2
XOM
57
-2
ITW
48
9
MCK
64
2
LOW
24
-4
AMGN
39
-5
CI
45
2
HP
36
2
ORLY
58
8
ACN
22
6
CNP
70
2
PFE
45
-15
KMX
42
2
KO
47
3
AIV
34
4
BSX
42
2
INTC
61
5
AES
46
2
PG
20
-2
WM
80
6
TXT
70
-2
XOM
57
-2
ITW
48
9
MCK
64
2
LOW
24
-4
AMGN
39
-5
Financhill
Back

Bureau Veritas SA Vs. BridgeBio Pharma, Inc. Industry Stock Comparison

Sell
41

BVVBY
Bureau Veritas SA

Last Price:
$60.93
Seasonality Move:
-3.56%
Buy
51

BBIO
BridgeBio Pharma, Inc.

Last Price:
$73.17
Seasonality Move:
5.25%
Sell
41
Bureau Veritas SA (BVVBY) is a Sell

Is Bureau Veritas SA a Buy, Sell or Hold?

  • The current Bureau Veritas SA [BVVBY] share price is $60.93. The Score for BVVBY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BVVBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BridgeBio Pharma, Inc. (BBIO) is a Buy

Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?

  • The current BridgeBio Pharma, Inc. [BBIO] share price is $73.15. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BVVBY Stock Price Chart

What is Bureau Veritas SA's stock price today?

  • The Bureau Veritas SA share price today is $60.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BVVBY is experiencing slight buying pressure.

BBIO Stock Price Chart

What is BridgeBio Pharma, Inc.'s stock price today?

  • The BridgeBio Pharma, Inc. share price today is $73.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.

BVVBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.44 Sell
Relative Strength Index (14 RSI): 39.22 Sell
Chaikin Money Flow: 3256 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.58 - 66.82) Sell
Bollinger Bands (100): (61.69 - 65.99) Sell

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 55.21 Buy
Chaikin Money Flow: -128497 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.58 - 72.4) Buy
Bollinger Bands (100): (67.73 - 76.59) Buy

BVVBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.38 Buy
20-day SMA: 62.62 Sell
50-day SMA: 64.52 Sell
200-day SMA: 63.73 Sell
8-day EMA: 60.72 Buy
20-day EMA: 62.16 Sell
50-day EMA: 63.54 Sell
200-day EMA: 63.63 Sell

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.71 Buy
20-day SMA: 70.4 Buy
50-day SMA: 71.53 Buy
200-day SMA: 61.39 Buy
8-day EMA: 72.08 Buy
20-day EMA: 70.93 Buy
50-day EMA: 70.94 Buy
200-day EMA: 62.01 Buy

Bureau Veritas SA Earnings Growth & BVVBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.

Bureau Veritas SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):